Clinical Trial Update: Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH) [NA]

View source ↗

Summary

Update on the RELIEVE-PAH trial evaluating a V-Wave device to reduce right ventricular failure in pulmonary arterial hypertension. The study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• V-Wave device

Snippet

Sponsor: V-Wave Ltd | Conditions: Pulmonary Arterial Hypertension | NA | Status: RECRUITING